Clinical study of 99mTc-Rituximab combined with dyes double tracing for axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer

Clinical study of 99mTc-Rituximab combined with dyes double tracing for axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer

Background and objectiveWhether sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NAC) for breast cancer is an alternative to axillary lymph node dissection (ALND) remains controversial. In this study, the results of SLNB performed with 99mTc-Rituximab combined with dyes were analyze...

Full description

Saved in:
Bibliographic Details
Main Authors: Minxue Zhuang, Yidan Lin, HongBin Qiu, Wei Chen, Ruo Wang, HuanHong Zeng, Mengbo Lin, Hui Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
breast cancer
neoadjuvant chemotherapy (NAC)
sentinel lymph node biopsy (SLNB)
99mTc-Rituximab
axillary lymph node dissection (ALND)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1568550/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items